Novartis Sues Lupin, Torrent Over Blood-Pressure Medicine - Bloomberg

Novartis, based in Basel, Switzerland, is counting on new products, including Exforge, to help replace revenue lost when the company’s best sellers, Diovan for hypertension and Gleevac for leukemia, start to lose U.S. patent protection later ...

Novartis: A Sleeper Or A Headache? - Seekingalpha.com

This last quarter, Novartis missed the street estimates mainly because of looming patent expiration of some of their best-selling prescription drugs, most notably Diovan (valsartan). In their conference call on April 24th, Novartis touched on the impact of ...

Generic Plavix® to Arrive at All Walmart and Sam's Club Pharmacies on May 19 - Marketwatch

BENTONVILLE, Ark., May 16, 2012 /PRNewswire via COMTEX/ -- Walmart (NYSE:WMT) announced today that it will be among the first retailers to offer Clopidogrel, the generic version of Plavix®. Clopidogrel will be available at all Walmart and Sam's ...

America's Pink Slip Capitals - Forbes

The $56 billion-in-sales company is going through a restructuring due to the pending patent expiration of its top-selling hypertension drug, Diovan. In and around Chicago, which is third on our list, some 6,000 workers were hit by mass layoffs.

Novartis: A Deeply Undervalued Buy At $54 - Seekingalpha.com

The acquisition comes at a telling time for Novartis. The company reported a first quarter profit slide 8% on slumping sales of its over the counter medicines and top selling drug Diovan. Sales of the blood pressure medication fell down by 15% to $1.2 ...

Buy Ranbaxy Laboratories; target Rs 559: Emkay - MoneyControl.com

Margins will expand by 400bps in CY12 and 200bps in CY13. Strong Para IV pipeline which includes Actos and Diovan will contribute USD315mn in revenues and EPS of Rs23 in CY12/ 13E. Company has entered into consent decree with USFDA. Resolution ...

Flatulence from high-fiber snack bar - CharlotteObserver.com

The Food and Drug Administration recently issued a warning that Tekturna should not be taken with drugs like Diovan, enalapril, lisinopril and losartan by people with diabetes. Anyone with reduced kidney function also should avoid such combinations.

How High Can Biogen Idec Fly? - Daily Finance

Novartis offers the highest dividend yield to value investors, but it also is preparing to lose its blockbuster high-blood-pressure treatment Diovan to patent expiration in September this year and is expected to grow the slowest over the next five years.

Finding Stability Amid Europe Woes - Yahoo Finance

While the 2012 patent loss on Diovan and manufacturing problems in the consumer division will weigh on near-term growth, the company's strong strategic position should lead to robust long-term growth.